Cargando…
Challenges to Early Discharge of Patients with Upper Urinary Tract Infections by ESBL Producers: TMP/SMX as a Step-Down Therapy for Shorter Hospitalization and Lower Costs
BACKGROUND: Urinary tract infections (UTIs) caused by extended spectrum beta-lactamase (ESBL) producing pathogens have increased and are treated with carbapenem in general. Carbapenem use is associated with prolonged hospitalization or daily outpatient visit. The aim of this study was to investigate...
Autores principales: | Shi, Hye Jin, Wee, Jae Hee, Eom, Joong Sik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422030/ https://www.ncbi.nlm.nih.gov/pubmed/34511950 http://dx.doi.org/10.2147/IDR.S321888 |
Ejemplares similares
-
TMP-SMX induced type 4 hypersensitivity with multi-organ involvement
por: Sircar, Samantha, et al.
Publicado: (2023) -
Antibody- Based Immunotherapy Combined With Antimycotic Drug TMP- SMX to Treat Infection With Paracoccidioides brasiliensis
por: Boniche-Alfaro, Camila, et al.
Publicado: (2021) -
210. Step-down from IV to oral therapy in patients with bacteremia due to Enterobacteriaceae: fluoroquinolones (FQ) vs. ß-lactams (BL) or trimethoprim-sulfamethoxazole (TMP-SMX)
por: Meng, Lina, et al.
Publicado: (2019) -
Low-Dose TMP-SMX in the Treatment of Pneumocystis jirovecii Pneumonia: A Systematic Review and Meta-analysis
por: Butler-Laporte, Guillaume, et al.
Publicado: (2020) -
1304. Antimicrobial Management of Stenotrophomonas maltophilia Pneumonia: Does TMP-SMX Dose Affect Treatment Failure?
por: Keck, J Myles, et al.
Publicado: (2021)